Auwaerter Paul Gisbert bought CAPR
January 2, 2024 · Form 4 insider transaction
Auwaerter Paul Gisbert bought 6,760 shares of Capricor Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,760
Price
$0.00
Total value
N/A
InsiderAuwaerter Paul Gisbert
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2024
Filing dateJanuary 4, 2024
Shares owned after6,760
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service.